There were 1,715 press releases posted in the last 24 hours and 359,324 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Achaogen Announces Enrollment of First Patient in EPIC, a Phase 3 Clinical Trial for the Treatment of Complicated Urinary Tract Infections (cUTI) With Plazomicin

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image